Clinical Trials
5 trialsNCT07152236 2026-05-28
Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors
Guangzhou Bio-gene Technology Co., Ltd
Phase NA Withdrawn
NCT00828919 2024-12-03
Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials
Pfizer
Phase NA Completed
NCT03998345 2020-09-09
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase NA Unknown
NCT01369433 2020-09-01
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
AVEO Pharmaceuticals, Inc.
Phase NA Terminated
NCT00798889 2013-01-21
Rollover Protocol for Prior SU011248 Protocols
Pfizer
Phase NA Completed